Glimeryl-Mepha 1 mg

Glimeryl-Mepha 1 mg is a medicine authorised by Swissmedic under authorisation number 57611. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 October 2006 and the authorisation is limited until 01 December 2026. ATC code A10BB12 places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 57611
  • ATC A10BB12
  • Synthetic medicines
Authorisation data
Authorisation number57611
NameGlimeryl-Mepha 1 mg
Full nameGlimeryl-Mepha 1 mg, Tabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA10BB12
First authorisation10 October 2006
Authorisation validity01 December 2026
Strengths
No.NameDispensing categoryAuthorisation date
1Glimeryl-Mepha 1 mg, TablettenB10 October 2006
2Glimeryl-Mepha 2 mg, TablettenB10 October 2006
3Glimeryl-Mepha 3 mg, TablettenB10 October 2006
4Glimeryl-Mepha 4 mg, TablettenB10 October 2006

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)A10BB1207.06.2.B
2120Tablette(n)A10BB1207.06.2.B
330Tablette(n)A10BB1207.06.2.B
4120Tablette(n)A10BB1207.06.2.B
530Tablette(n)A10BB1207.06.2.B
6120Tablette(n)A10BB1207.06.2.B
730Tablette(n)A10BB1207.06.2.B
8120Tablette(n)A10BB1207.06.2.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Glimeryl-Mepha 1 mg authorised in Switzerland?

Yes. Glimeryl-Mepha 1 mg is authorised by Swissmedic under authorisation number 57611, data as of 01 September 2026. The authorisation is limited until 01 December 2026.

Which dispensing category does Glimeryl-Mepha 1 mg have?

Glimeryl-Mepha 1 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Glimeryl-Mepha 1 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com